PRIMECAP MANAGEMENT CO/CA/ - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRIMECAP MANAGEMENT CO/CA/ ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$796,736
-18.8%
146,1900.0%0.00%0.0%
Q2 2023$980,935
-24.0%
146,1900.0%0.00%0.0%
Q1 2023$1,290,858
+15.6%
146,1900.0%0.00%0.0%
Q4 2022$1,116,892
+4.2%
146,190
-2.9%
0.00%0.0%
Q3 2022$1,072,000
-12.0%
150,5000.0%0.00%0.0%
Q2 2022$1,218,000
-55.1%
150,500
-23.0%
0.00%
-50.0%
Q1 2022$2,714,000
-51.8%
195,500
-2.5%
0.00%
-50.0%
Q4 2021$5,626,000
-19.5%
200,500
-2.4%
0.00%
-20.0%
Q3 2021$6,985,000
-22.1%
205,500
-6.4%
0.01%
-16.7%
Q2 2021$8,969,000
+5.8%
219,500
+4.3%
0.01%0.0%
Q1 2021$8,475,000
+11.5%
210,500
+63.8%
0.01%0.0%
Q4 2020$7,598,000
-9.4%
128,500
-25.5%
0.01%
-14.3%
Q3 2020$8,389,000
+15.2%
172,500
+14.6%
0.01%
+16.7%
Q2 2020$7,281,000
+74.1%
150,5000.0%0.01%
+50.0%
Q1 2020$4,181,000150,5000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders